awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q30790872-498B483F-62E3-4961-BA61-FDBD3487BFF0
Q30790872-498B483F-62E3-4961-BA61-FDBD3487BFF0
BestRank
Statement
http://www.wikidata.org/entity/statement/Q30790872-498B483F-62E3-4961-BA61-FDBD3487BFF0
Selection of high affinity human neutralizing antibodies to VEGFR2 from a large antibody phage display library for antiangiogenesis therapy.
P2860
Q30790872-498B483F-62E3-4961-BA61-FDBD3487BFF0
BestRank
Statement
http://www.wikidata.org/entity/statement/Q30790872-498B483F-62E3-4961-BA61-FDBD3487BFF0
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
91a9cc9c177248b8cf2194f08e5cf7c41f1b572b
P2860
Phase Ib trial of intravenous recombinant humanized monoclonal antibody to vascular endothelial growth factor in combination with chemotherapy in patients with advanced cancer: pharmacologic and long-term safety data.